Frequencies of CD33+CD11b+HLA-DR–CD14–CD66b+ and CD33+CD11b+HLA-DR–CD14+CD66b– Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19-Reference-Cited by-同舟云学术

Frequencies of CD33+CD11b+HLA-DR–CD14–CD66b+ and CD33+CD11b+HLA-DR–CD14+CD66b– Cells in Peripheral Blood as Severity Immune Biomarkers in COVID-19

Published:2020-10-14 Issue: Volume:7 Page:
ISSN:2296-858X
Container-title:Frontiers in Medicine
language:
Short-container-title:Front. Med.

Author:

Alberca Ricardo Wesley,Andrade Milena Mary de Souza,Branco Anna Cláudia Calvielli Castelo,Pietrobon Anna Julia,Pereira Nátalli Zanete,Fernandes Iara Grigoletto,Oliveira Luana de Mendonça,Teixeira Franciane Mouradian Emidio,Beserra Danielle Rosa,de Oliveira Emily Araujo,Gozzi-Silva Sarah Cristina,Ramos Yasmim Álefe Leuzzi,de Brito Cyro Alves,Arnone Marcelo,Orfali Raquel Leao,Aoki Valeria,Duarte Alberto Jose da Silva,Sato Maria Notomi

Funder

Fundação de Amparo à Pesquisa do Estado de São Paulo

Coordenação de Aperfeiçoamento de Pessoal de Nível Superior

Publisher

Frontiers Media SA

Subject

General Medicine

Reference18 articles.

1. Clinical, laboratory and imaging features of COVID-19: a systematic review and meta-analysis;Rodriguez-Morales;Travel Med Infect Dis.,2020

2. Neutrophil-to-lymphocyte ratio as an independent risk factor for mortality in hospitalized patients with COVID-19;Liu;J Infect.,2020

3. Immune phenotyping based on the neutrophil-to-lymphocyte ratio and IgG level predicts disease severity and outcome for patients with COVID-19;Zhang;Front Mol Biosci.,2020

4. Elevated levels of IL-6 and CRP predict the need for mechanical ventilation in COVID-19;Herold;J Allergy Clin Immunol.,2020

5. Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China;Huang;Lancet.,2020

Cited by 13 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Platelet Indices as Novel Surrogate Markers for the Prognosis of COVID-19 Infection: An Observational Study;Cureus;2024-06-12

2. Relevance of TMPRSS2, CD163/CD206, and CD33 in clinical severity stratification of COVID-19;Frontiers in Immunology;2023-03-08

3. Innate and Adaptive Immunity during SARS-CoV-2 Infection: Biomolecular Cellular Markers and Mechanisms;Vaccines;2023-02-10

4. Long-term effects of COVID-19 in diabetic and non-diabetic patients;Frontiers in Public Health;2022-08-15

5. IMMUNE PROFILING UNCOVERS POTENT ADJUVANT CAPACITIES OF SARS-COV-2 INFECTION TO VACCINATION LEADING TO MEMORY T CELL RESPONSES WITH A TH17 SIGNATURE IN CANCER PATIENTS;2022-05-27